Renal therapy using tissue-engineered constructs and gene delivery

Gilad E. Amid, James J. Yoo, Anthony Atala

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Currently available renal replacement therapies are not optimal for most patients. In addition to the inherent shortage of transplant organs, significant complications are associated with renal transplantation and immunosuppressive therapy. Dialysis neglects the resorptive, homeostatic, metabolic, and endocrinologic functions of the kidney and only partially replaces its filtration properties, resulting in morbidity and mortality. Application of tissue-engineering techniques may improve many aspects of renal function replacement. Identification of the growth factors capable of directing tissue development and of the technique to be used for their delivery would aid in the engineering of human tissue. The combination of tissue-engineering strategies with gene therapy might allow the transfection of diseased tissues with designated cDNA to eliminate inherent or acquired defects. Devices that have been targeted at replacing a single aspect of renal function, in addition to three-dimensional renal units that are capable of excreting urine-like solutes, have been used experimentally. Combination of these strategies may allow the formation of tissue-engineered kidneys in the future.

Original languageEnglish
Pages (from-to)71-79
Number of pages9
JournalWorld Journal of Urology
Volume18
Issue number1
StatePublished - Dec 1 2000
Externally publishedYes

Fingerprint

Cell- and Tissue-Based Therapy
Kidney
Tissue Engineering
Genes
Renal Replacement Therapy
Human Engineering
Immunosuppressive Agents
Genetic Therapy
Kidney Transplantation
Transfection
Dialysis
Intercellular Signaling Peptides and Proteins
Complementary DNA
Urine
Morbidity
Transplants
Equipment and Supplies
Mortality
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Amid, G. E., Yoo, J. J., & Atala, A. (2000). Renal therapy using tissue-engineered constructs and gene delivery. World Journal of Urology, 18(1), 71-79.

Renal therapy using tissue-engineered constructs and gene delivery. / Amid, Gilad E.; Yoo, James J.; Atala, Anthony.

In: World Journal of Urology, Vol. 18, No. 1, 01.12.2000, p. 71-79.

Research output: Contribution to journalArticle

Amid, GE, Yoo, JJ & Atala, A 2000, 'Renal therapy using tissue-engineered constructs and gene delivery', World Journal of Urology, vol. 18, no. 1, pp. 71-79.
Amid, Gilad E. ; Yoo, James J. ; Atala, Anthony. / Renal therapy using tissue-engineered constructs and gene delivery. In: World Journal of Urology. 2000 ; Vol. 18, No. 1. pp. 71-79.
@article{aee3a659ab954fd8867d8513d6035f96,
title = "Renal therapy using tissue-engineered constructs and gene delivery",
abstract = "Currently available renal replacement therapies are not optimal for most patients. In addition to the inherent shortage of transplant organs, significant complications are associated with renal transplantation and immunosuppressive therapy. Dialysis neglects the resorptive, homeostatic, metabolic, and endocrinologic functions of the kidney and only partially replaces its filtration properties, resulting in morbidity and mortality. Application of tissue-engineering techniques may improve many aspects of renal function replacement. Identification of the growth factors capable of directing tissue development and of the technique to be used for their delivery would aid in the engineering of human tissue. The combination of tissue-engineering strategies with gene therapy might allow the transfection of diseased tissues with designated cDNA to eliminate inherent or acquired defects. Devices that have been targeted at replacing a single aspect of renal function, in addition to three-dimensional renal units that are capable of excreting urine-like solutes, have been used experimentally. Combination of these strategies may allow the formation of tissue-engineered kidneys in the future.",
author = "Amid, {Gilad E.} and Yoo, {James J.} and Anthony Atala",
year = "2000",
month = "12",
day = "1",
language = "English",
volume = "18",
pages = "71--79",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Renal therapy using tissue-engineered constructs and gene delivery

AU - Amid, Gilad E.

AU - Yoo, James J.

AU - Atala, Anthony

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Currently available renal replacement therapies are not optimal for most patients. In addition to the inherent shortage of transplant organs, significant complications are associated with renal transplantation and immunosuppressive therapy. Dialysis neglects the resorptive, homeostatic, metabolic, and endocrinologic functions of the kidney and only partially replaces its filtration properties, resulting in morbidity and mortality. Application of tissue-engineering techniques may improve many aspects of renal function replacement. Identification of the growth factors capable of directing tissue development and of the technique to be used for their delivery would aid in the engineering of human tissue. The combination of tissue-engineering strategies with gene therapy might allow the transfection of diseased tissues with designated cDNA to eliminate inherent or acquired defects. Devices that have been targeted at replacing a single aspect of renal function, in addition to three-dimensional renal units that are capable of excreting urine-like solutes, have been used experimentally. Combination of these strategies may allow the formation of tissue-engineered kidneys in the future.

AB - Currently available renal replacement therapies are not optimal for most patients. In addition to the inherent shortage of transplant organs, significant complications are associated with renal transplantation and immunosuppressive therapy. Dialysis neglects the resorptive, homeostatic, metabolic, and endocrinologic functions of the kidney and only partially replaces its filtration properties, resulting in morbidity and mortality. Application of tissue-engineering techniques may improve many aspects of renal function replacement. Identification of the growth factors capable of directing tissue development and of the technique to be used for their delivery would aid in the engineering of human tissue. The combination of tissue-engineering strategies with gene therapy might allow the transfection of diseased tissues with designated cDNA to eliminate inherent or acquired defects. Devices that have been targeted at replacing a single aspect of renal function, in addition to three-dimensional renal units that are capable of excreting urine-like solutes, have been used experimentally. Combination of these strategies may allow the formation of tissue-engineered kidneys in the future.

UR - http://www.scopus.com/inward/record.url?scp=0034137293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034137293&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 71

EP - 79

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 1

ER -